Showing 1 - 1 results of 1 for search '"лактобациллы LC-11"', query time: 0.42s Refine Results
  1. 1
    Academic Journal

    Source: Obstetrics, Gynecology and Reproduction; Vol 17, No 4 (2023); 485-499 ; Акушерство, Гинекология и Репродукция; Vol 17, No 4 (2023); 485-499 ; 2500-3194 ; 2313-7347

    File Description: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/1767/1136; Getaneh T., Negesse A., Dessie G. et al. Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:6551526. https://doi.org/10.1155/2021/6551526.; Chelkeba L., Fanta K., Mulugeta T., Melaku T. Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and metaanalysis. Arch Gynecol Obstet. 2022;306(3):663–86. https://doi.org/10.1007/s00404-021-06365-4.; González-Garay A., Velasco-Hidalgo L., Ochoa-Hein E., Rivera-Luna R. Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis. Int Urogynecol J. 2021;32(1):3–15. https://doi.org/10.1007/s00192-020-04255-y.; Lenger S.M., Bradley M.S., Thomas D.A. et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.; Зайцев А.В., Перепанова Т.С., Гвоздев М.Ю., Арефьева О.А. Инфекции мочевыводящих путей: методические рекомендации № 57. М.: АБВ-пресс, 2018. 26 с.; Delcaru C., Alexandru I., Podgoreanu P. et al. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. https://doi.org/10.3390/pathogens5040065.; McMillan A., Dell M., Zellar M.P. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011;86(1):58–64. https://doi.org/10.1016/j.colsurfb.2011.03.016.; Soto M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;5:1–13. https://doi.org/10.1155/2014/543974.; Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. https://doi.org/10.1038/nrmicro821.; Parsek M.R., Singh P.K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677–701. https://doi.org/10.1146/annurev.micro.57.030502.090720.; Imamura Y., Chandra J., Mukherjee P.K. et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52(1):171–82. https://doi.org/10.1128/AAC.00387-07.; Patterson J.L., Girerd P.H., Karjane N.W., Jefferson K.K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197(2):170.e1–7. https://doi.org/10.1016/j.ajog.2007.02.027.; Patterson J.L., Stull-Lane A., Girerd P.H., Jefferson K.K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosisassociated anaerobes. Microbiology (Reading). 2010;156(Pt 2):392–9. https://doi.org/10.1099/mic.0.034280-0.; Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–6. https://doi.org/10.1016/j.ajog.2007.06.039.; Rogers A.H. Molecular oral microbiology. Caister Academic Press, 2008. 292 p. https://doi.org/10.21775/9781912530069.; Gondil V.S., Subhadra B. Biofilms and their role on diseases. BMC Microbiol. 2023;23(1):203. https://doi.org/10.1186/s12866-023-02954-2.; Garg S.S., Dubey R., Sharma S. et al. Biological macromolecules-based nanoformulation in improving wound healing and bacterial biofilmassociated infection: a review. Int J Biol Macromol. 2023;247:125636. https://doi.org/10.1016/j.ijbiomac.2023.125636.; Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье: руководство. M.: ГЭОТАР-Медиа, 2019. 672 с.; Tabasi M., Asadi Karam M.R., Habibi M. et al. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261–8. https://doi.org/10.1016/j.phrp.2015.08.002.; Komesu Y.M., Dinwiddie D.L., Richter H.E. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011.; Murina F., Graziottin A., Felice R., Di Francesco S. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Eur J Obstet Gynecol Reprod Biol. 2016;207:121–4. https://doi.org/10.1016/j.ejogrb.2016.10.016.; Shim Y.H., Lee S.J., Lee J.W. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016;58(10):1009–13. https://doi.org/10.1111/ped.12949.; Schwendicke F., Korte F., Dörfer C.E. et al. Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro. Caries Res. 2017;51(2):87–95. https://doi.org/10.1159/000452960.; Gomes A.C., Hoffmann C., Mota J.F. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2020;59(4):1751–62. https://doi.org/10.1007/s00394-019-02034-0.; Cannarella L.A.T., Mari N.L., Alcântara C.C. et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition. 2021;89:111282. https://doi.org/10.1016/j.nut.2021.111282.; Громова О.А., Торшин И.Ю., Тетруашвили Н.К. Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста. Акушерство, Гинекология и Репродукция. 2019;13(2):119–31. https://doi.org/10.17749/2313-7347.2019.13.2.119-131.; Торшин И.Ю., Аполихина И.А., Громов А.Н., Громова О.А. Свойства D-маннозы: противовоспалительный и противоопухолевый эффекты. Экспериментальная и клиническая урология. 2020;(2):164–70. https://doi.org/10.29188/2222-8543-2020-12-2-164-170.; Торшин И.Ю., Галустян А.Н., Иванова М.И. и др. Хемомикробиомный анализ синергизма D-маннозы и D-фруктозы в сравнении с другими метабиотиками. Эффективная фармакотерапия. 2020;16(20):22–31. https://doi.org/10.33978/2307-3586-2020-16-20-22-31.; Eden C.S., Hagberg L., Hanson L.A. et al. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–87. https://doi.org/10.1002/9780470720639.ch11.; Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannosesensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10. https://doi.org/10.1016/s0022-5347(17)50706-5.; Agata N., Ohta M., Miyazawa H. et al. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections. Eur J Clin Microbiol Infect Dis. 1989;8(2):156–9. https://doi.org/10.1007/BF01963903.; Nowicki B., Svanborg-Eden C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989;57(2):446–51. https://doi.org/10.1128/iai.57.2.446-451.1989.; Cordeiro M.A., Werle C.H., Milanez G.P., Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–6. https://doi.org/10.1016/j.bjm.2016.01.024.; Pani A., Valeria L., Dugnani S. et al. Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. J Chemother. 2022;34(7):459–64. https://doi.org/10.1080/1120009X.2022.2061184.; Toyota S., Fukushi Y., Katoh S. et al. Anti-bacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816–23. (In Japanese). https://doi.org/10.5980/jpnjurol1989.80.1816.; De Nunzio C., Bartoletti R., Tubaro A. et al. Role of D-mannose in the prevention of recurrent uncomplicated cystitis: state of the art and future perspectives. Antibiotics. 2021;10(4):373. https://doi.org/10.3390/antibiotics10040373.; Торшин И.Ю., Громова О.А. Под ред. А.Г. Чучалина А.Г. Микронутриенты против коронавирусов. Вчера, сегодня, завтра. M.: ГЭОТАРМедиа, 2023. 448 с.; Берников А.Н., Куприянов Ю.А., Строганов Р.В. и др. Симптомы нижних мочевыводящих путей и COVID-19. Урология. 2021;(5):78–83. https://doi.org/10.18565/urology.2021.5.78-83.; Mitrani-Gold F.S., Raychaudhuri A., Rao S. Systematic review and metaanalysis to estimate the antibacterial treatment effect of nitrofurantoin for a non-inferiority trial in uncomplicated urinary tract infection. J Glob Antimicrob Resist. 2020;22:68–77. https://doi.org/10.1016/j.jgar.2020.01.027.; Agresti A., Caffo B. Simple and effective confidence Intervals for proportions and differences of proportions result from adding two successes and two failures. Am Stat. 2000;54(4):280–8.; Falagas M.E., Vouloumanou E.K., Togias A.G. et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65(9):1862–77. https://doi.org/10.1093/jac/dkq237.; Alfaresi M., Hassan K., Alnjadat R.M.H. Single-dose Fosfomycin trometamol versus other antimicrobial regimens for treatment of uncomplicated lower urinary tract infection: a systematic review and meta-analysis. Open Microbiol J. 2019;13(1):193–9. https://doi.org/10.2174/1874285801913010193.; Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6.; Wagenlehner F., Lorenz H., Ewald O., Gerke P. Why D-mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections-preliminary considerations and conclusions from a non-interventional study. Antibiotics. 2022;11(3):314. https://doi.org/10.3390/antibiotics11030314.; Kaur R., Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803–12. https://doi.org/10.1136/postgradmedj-2020-139090.; Chiu K., Zhang F., Sutcliffe S. et al. Recurrent urinary tract infection incidence rates decrease in women with cystitis cystica after treatment with D-mannose: a cohort study. Female Pelvic Med Reconstr Surg. 2022;28(3):e62–e65. https://doi.org/10.1097/SPV.0000000000001144.; Harmidy K., Tufenkji N., Gruenheid S. Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One. 2011;6(11):e27267. https://doi.org/10.1371/journal.pone.0027267.; Howell A.B., Reed J.D., Krueger C.G. et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281–91. https://doi.org/10.1016/j.phytochem.2005.05.022.; Parazzini F., Ricci E., Fedele F. et al. Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep. 2022;17(2):69. https://doi.org/10.3892/br.2022.1552.; Fu Z., Liska D., Talan D., Chung M. Cranberry reduces the risk of urinary tract infection recurrence in otherwise healthy women: a systematic review and meta-analysis. J Nutr. 2017;147(12):2282–8. https://doi.org/10.3945/jn.117.254961.; DE Leo V., Cappelli V., Massaro M.G. et al. Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol. 2017;69(4):336–41. (In Italian). https://doi.org/10.23736/S0026-4784.17.04074-6.; Xia J.Y., Yang C., Xu D.F. et al. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis. PLoS One. 2021;16(9):e0256992. https://doi.org/10.1371/journal.pone.0256992.; Raditic D.M. Complementary and integrative therapies for lower urinary tract diseases. Vet Clin North Am Small Anim Pract. 2015;45(4):857–78. https://doi.org/10.1016/j.cvsm.2015.02.009.; Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48 Suppl 1:S96–101. https://doi.org/10.1097/MCG.0000000000000224.; Murina F., Vicariotto F., Lubrano C. Efficacy of an orally administered combination of Lactobacillus paracasei LC11, cranberry and D-mannose for the prevention of uncomplicated, recurrent urinary tract infections in women. Urologia. 2021;88(1):64–68. https://doi.org/10.1177/0391560320957483.; https://www.gynecology.su/jour/article/view/1767